Discovery Life Sciences and Mindpeak Partner for AI Cancer Biomarker Testing
Discovery Life Sciences and Mindpeak partner to bring AI-driven cancer biomarker testing in global clinical trials, aiming to reduce variability in biomarker interpretation and improve accuracy in drug development.
Mindpeak | 25/03/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy